Search - Université de Rennes Access content directly

Filter your results

10 Results
Author: personID (integer) : 972533

Venetoclax-Targeted Therapy in t(11;14) AL Amyloidosis Patients after Frontline Daratumumab and Cybord: A Retrospective Analysis from the French Amyloidosis Network

Murielle Roussel , Michelle Pirotte , Ornella Rizzo , Kentin Queru , Thomas Chalopin et al.
64th ASH Annual Meeting and Exposition, Dec 2022, New Orleans, United States. pp.10086-10087, ⟨10.1182/blood-2022-166224⟩
Conference papers hal-04071489v1

A genome-wide association study identifies susceptibility loci for primary central nervous system lymphoma at 6p25.3 and 3p22.1: a LOC Network study

Karim Labreche , Mailys Daniau , Amit Sud , Philip J Law , Louis Royer-Perron et al.
Neuro-Oncology, 2019, 21 (8), pp.1039-1048. ⟨10.1093/neuonc/noz088⟩
Journal articles hal-02328989v1

Carfilzomib maintenance in newly diagnosed non-transplant eligible multiple myeloma

Arthur Bobin , Maéva Kyheng , Stephanie Guidez , Cecile Gruchet-Merouze , Valentine Richez et al.
Leukemia, 2022, 36 (3), pp.881-884. ⟨10.1038/s41375-021-01415-x⟩
Journal articles hal-03476700v1

Efficacy of bortezomib, cyclophosphamide and dexamethasone in treatment-naïve patients with high-risk cardiac AL amyloidosis (Mayo Clinic stage III).

Arnaud Jaccard , Raymond L. Comenzo , Parameswaran Hari , Philip N. Hawkins , Murielle Roussel et al.
Haematologica, 2014, 99 (9), pp.1479-85. ⟨10.3324/haematol.2014.104109⟩
Journal articles hal-01064573v1

Carfilzomib Weekly Plus Melphalan and Prednisone in Newly Diagnosed Elderly Multiple Myeloma (IFM 2012-03) / 57th Annual Meeting of the American-Society-of-Hematology - Orlando, FL

Xavier Leleu , Lionel Karlin , Brigitte Kolb , Mourad Tiab , Carla Araujo et al.
Blood, 2015, 126 (23), pp.3028
Journal articles hal-01290431v1

Primary CNS lymphoma at first relapse/progression: characteristics, management, and outcome of 256 patients from the French LOC network

Sophie Langner-Lemercier , Caroline Houillier , Carole Soussain , Hervé Ghesquières , Olivier Chinot et al.
Neuro-Oncology, 2016, 18 (9), pp.1297-1303. ⟨10.1093/neuonc/now033⟩
Journal articles hal-01290413v1

A 1-Year Prospective French Nationwide Study of Emergency Hospital Admissions in Children and Adults with Primary Immunodeficiency

Hélène Coignard-Biehler , Nizar Mahlaoui , Benoît Pilmis , Vincent Barlogis , Pauline Brosselin et al.
Journal of Clinical Immunology, 2019, 39 (7), pp.702-712. ⟨10.1007/s10875-019-00658-9⟩
Journal articles hal-02377907v1

A Prospective Phase II Trial of Lenalidomide and Dexamethasone (Len-Dex) in POEMS Syndrome

Arnaud Jaccard , A. Danielou-Lazareth , L. Karlin , S. Choquet , L. Frenzel et al.
15th International Myeloma Workshop, Sep 2015, Rome, Italy. pp.e57, ⟨10.1016/j.clml.2015.07.197⟩
Conference papers hal-01228183v1

Genetic diagnosis of primary immunodeficiencies: A survey of the French national registry

Nizar Mahlaoui , Capucine Picard , Perrine Bach , Laurence Costes , Virginie Courteille et al.
Journal of Allergy and Clinical Immunology, 2019, 143 (4), pp.1646-1649.e10. ⟨10.1016/j.jaci.2018.12.994⟩
Journal articles hal-02015219v1
Image document

Molecular response after obinutuzumab plus high-dose cytarabine induction for transplant-eligible patients with untreated mantle cell lymphoma (LyMa-101): a phase 2 trial of the LYSA group

Steven Le Gouill , Asma Beldi-Ferchiou , Marion Alcantara , Victoria Cacheux , Violaine Safar et al.
Lancet Haematology, 2020, 7 (11), pp.e798-e807. ⟨10.1016/S2352-3026(20)30291-X⟩
Journal articles hal-03012903v1